Analysis HealthBeacon PLC (HBCNF)
5/30/2024
Analysis of HealthBeacon PLC (HBCNF)
HealthBeacon PLC (HBCNF) has been trading at a consistent price of 0.55 for the past few days. The Relative Strength Index (RSI) is quite high at around 89.77, indicating that the stock may be overbought.Looking at the Moving Average Convergence Divergence (MACD) indicator, the MACD line is below the signal line, with a negative MACD histogram. This suggests a bearish signal for the stock.
In terms of moving averages, the Simple Moving Average (SMA) and Exponential Moving Average (EMA) are both above the current price, indicating a potential downward trend.
Overall, based on the RSI, MACD, and moving averages, the stock may be overvalued and could potentially see a downward correction in the near future. Investors should exercise caution and consider their risk tolerance before making any trading decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not supplied at the time. The results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a total cash position and total debt level indicated in the balance sheet. The profit margin, operating margin, return on assets, and return on equity metrics are also provided. The income statement shows figures such as EBITDA, revenue, diluted EPS, gross profit, net income, and various growth rates.
Stock statistics include details on short interest, float shares, trading volumes, shares outstanding, and ownership percentages. Valuation metrics cover ratios like PEG ratio, forward and trailing P/E ratios, price to book, price to sales, and various enterprise value multiples. The market capitalization is also specified.
The stock price summary includes beta, moving averages, and the range of the stock price over the past fifty-two weeks. Dividends and splits information includes payout ratio, dividend dates, split history, dividend rates, and yield metrics.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, ranging from around 38% to 44% over the same period.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has increased from $57.4 billion in 2020 to $97 billion in 2023, indicating improving profitability.
5. Earnings per share (EPS) have also been on the rise, with both basic and diluted EPS showing an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, hovering around 33% to 35%.
7. Despite fluctuations in certain expenses and taxes, the overall financial performance of the company seems to be on a positive trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist of leases, land, machinery, and investments.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown fluctuations but has generally been positive.
6. The company has been relying on short-term debt and accounts payable for its current liabilities.
7. Long-term debt is a significant portion of non-current liabilities.
8. The company has been investing in leases, machinery, and land improvements over the years.
9. Accumulated depreciation has been increasing, indicating aging assets.
10. The company has been retaining earnings and issuing common stock to strengthen shareholders' equity.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchases and long-term debt issuances, with significant variations in amounts each year.
4. Investing activities reflect a mix of acquisitions, capital expenditures, and investments, with notable changes in the sale and purchase of investments.
5. The end cash position has also varied, reaching its peak in 2020 and its lowest point in 2022.
6. Interest paid and income tax paid figures have fluctuated, impacting the company's overall cash flow position.
7. The company has been consistent in paying dividends and managing its cash flow through a combination of financing, investing, and operating activities.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next fiscal years. The average estimates are showing an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average growth rate for the past 5 years is 20.1% per annum.
6. Next 5 Years (per annum): The estimated growth rate for the next 5 years is 11% per annum.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical average. However, the company is still projected to experience solid growth over the next few years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
MACD of HBCNF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
